更正：弗拉芒等人。肿瘤抑制性miR-192-5p在胰腺导管腺癌中具有预后价值。2020年，，1693。 （你提供的原文中存在一些格式不清晰的地方，比如有多余的逗号等，可能会影响理解，我按照正确的翻译思路进行了处理。）
Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. 2020, , 1693.
作者信息
Flammang Isabelle, Reese Moritz, Ströse Anda J, Yang Zixuan, Eble Johannes A, Dhayat Sameer A
机构信息
Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany.
Department of Physiological Chemistry and Pathobiochemistry, University of Muenster, Waldeyerstrasse 15, 48149 Muenster, Germany.
出版信息
Cancers (Basel). 2024 Aug 12;16(16):2825. doi: 10.3390/cancers16162825.
Abstract
In the original publication [...].
摘要
在原始出版物中[...]。
相似文献
1
Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. 2020, , 1693.更正：弗拉芒等人。肿瘤抑制性miR-192-5p在胰腺导管腺癌中具有预后价值。2020年，，1693。 （你提供的原文中存在一些格式不清晰的地方，比如有多余的逗号等，可能会影响理解，我按照正确的翻译思路进行了处理。）
Cancers (Basel). 2024 Aug 12;16(16):2825. doi: 10.3390/cancers16162825.
2
Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma.肿瘤抑制性miR-192-5p在胰腺导管腺癌中具有预后价值。
Cancers (Basel). 2020 Jun 25;12(6):1693. doi: 10.3390/cancers12061693.
3
Impact of Oncogenic Targets Controlled by Tumor-Suppressive in Pancreatic Ductal Adenocarcinoma.抑癌基因调控的致癌靶点对胰腺导管腺癌的影响。
Anticancer Res. 2021 Oct;41(10):4821-4836. doi: 10.21873/anticanres.15297.
4
Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.术前血浆miR-21-5p是接受手术切除的胰腺导管腺癌患者的敏感生物标志物和独立预后因素。
Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):321-327. doi: 10.21873/cgp.20090.
5
Tumor suppressive role of miR-33a-5p in pancreatic ductal adenocarcinoma cells by directly targeting RAP2A.miR-33a-5p 通过直接靶向 RAP2A 在胰腺导管腺癌细胞中发挥肿瘤抑制作用。
Cell Mol Biol Lett. 2021 Jun 5;26(1):24. doi: 10.1186/s11658-021-00265-w.
6
Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.组织微小RNA谱作为可切除性胰腺导管腺癌和壶腹周围癌患者的诊断和预后生物标志物
Biomark Res. 2017 Feb 21;5:8. doi: 10.1186/s40364-017-0087-6. eCollection 2017.
7
MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting RAC1 in Pancreatic Ductal Adenocarcinoma.微小RNA-561-5p通过靶向RAC1抑制胰腺导管腺癌的细胞增殖和侵袭。
Ann Clin Lab Sci. 2022 Mar;52(2):213-221.
8
MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway.微小RNA-628-5p通过抑制AKT/核因子κB信号通路抑制人胰腺导管腺癌的侵袭和迁移。
J Cell Physiol. 2020 Nov;235(11):8141-8154. doi: 10.1002/jcp.29468. Epub 2020 Jan 19.
9
MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.miR-345-5p 通过直接靶向 CCL8 在胰腺癌中发挥肿瘤抑制作用。
Biomed Pharmacother. 2019 Mar;111:891-900. doi: 10.1016/j.biopha.2018.12.121. Epub 2019 Jan 7.
10
LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis.长链非编码 RNA PVT1 通过 miR-20a-5p/ULK1 轴触发细胞保护自噬并促进胰腺导管腺癌的发展。
Mol Cancer. 2018 Jul 12;17(1):98. doi: 10.1186/s12943-018-0845-6.
本文引用的文献
1
Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma.肿瘤抑制性miR-192-5p在胰腺导管腺癌中具有预后价值。
Cancers (Basel). 2020 Jun 25;12(6):1693. doi: 10.3390/cancers12061693.
Zotero 插件